{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:25:32Z","timestamp":1781533532871,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ajic.2015.08.007","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T05:28:39Z","timestamp":1444886919000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Racial and ethnic disparities in health care\u2013associated Clostridium difficile infections in the United States: State of the science"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-8592","authenticated-orcid":false,"given":"Sandra","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-3582","authenticated-orcid":false,"given":"Briana B.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Baehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Ducoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale J.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2015.08.007_bib1","unstructured":"Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs): data and statistics. 2015. Available from: http:\/\/www.cdc.gov\/HAI\/surveillance\/index.html. Accessed May 11,\u00a02015."},{"key":"10.1016\/j.ajic.2015.08.007_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajic.2015.08.007_bib3","unstructured":"Scott RD. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention. Available from: http:\/\/www.cdc.gov\/HAI\/pdfs\/hai\/Scott_CostPaper.pdf. Accessed April 24, 2015."},{"key":"10.1016\/j.ajic.2015.08.007_bib4","unstructured":"US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National action plan to prevent health care\u2013associated infections: road map to elimination. Available from: http:\/\/health.gov\/hcq\/pdfs\/hai-action-plan-cover-toc.pdf. Accessed April 24, 2015."},{"key":"10.1016\/j.ajic.2015.08.007_bib5","unstructured":"The White House. National Action Plan for Combating Antibiotic-Resistant Bacteria. Available from: https:\/\/www.whitehouse.gov\/sites\/default\/files\/docs\/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf. Accessed April 24, 2015."},{"key":"10.1016\/j.ajic.2015.08.007_bib6","unstructured":"Walter Reed Army Institute of Research. Multidrug-Resistant Organism Repository and Surveillance Network (MRSN). Available from: http:\/\/wrair-www.army.mil\/OtherServices_MRSN.aspx. Accessed May 26,\u00a02015."},{"key":"10.1016\/j.ajic.2015.08.007_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajic.2015.08.007_bib8","first-page":"157","article-title":"Vital signs: preventing Clostridium difficile infections","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajic.2015.08.007_bib9","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care\u2013associated infections: a meta-analysis of costs and financial impact on the US health care system","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajic.2015.08.007_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/cid\/ciu955","article-title":"The importance of considering different healthcare settings when estimating the burden of Clostridium difficile","volume":"60","author":"Kuntz","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.08.007_bib11","unstructured":"Centers for Disease Control and Prevention. Healthcare-associated infections (HAI) progress report. 2015. Available from: http:\/\/www.cdc.gov\/hai\/progress-report\/. Accessed March 2,\u00a02015."},{"key":"10.1016\/j.ajic.2015.08.007_bib12","unstructured":"Agency for Healthcare Research and Quality. Updated information on the annual hospital-acquired condition rate: 2011 and 2012. http:\/\/www.ahrq.gov\/professionals\/quality-patient-safety\/pfp\/hacrate2011-12.html. Accessed September\u00a02014."},{"key":"10.1016\/j.ajic.2015.08.007_bib13","unstructured":"Steiner C, BarrettM, Sun Y, Weiss A;US Agency for Healthcare Research and Quality. HCUP projections: Clostridium difficile hospitalizations 2003-2014. Available from: https:\/\/www.hcup-us.ahrq.gov\/reports\/projections\/2014-03.pdf. Accessed August 7, 2015."},{"key":"10.1016\/j.ajic.2015.08.007_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/cit492","article-title":"Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection","volume":"57","author":"Gould","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.08.007_bib15","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available from: http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/index.html. Accessed May 8,\u00a02015."},{"issue":"Suppl 2","key":"10.1016\/j.ajic.2015.08.007_bib16","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/cid\/civ140","article-title":"Current trends in the epidemiology and outcomes of Clostridium difficile infection","volume":"60","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.08.007_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajic.2012.02.021","article-title":"Clinical and economic outcomes from a community hospital's antimicrobial stewardship program","volume":"41","author":"Malani","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2015.08.007_bib18","first-page":"CD003543","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"4","author":"Davey","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajic.2015.08.007_bib19","unstructured":"Agency for Healthcare Research and Quality. Disparities in healthcare quality among racial and ethnic groups: selected findings from the 2011 National Healthcare Quality and Disparities reports. Available from: http:\/\/archive.ahrq.gov\/research\/findings\/nhqrdr\/nhqrdr11\/minority.html. Accessed May 7, 2015"},{"key":"10.1016\/j.ajic.2015.08.007_bib20","unstructured":"Heckler MM; US Department of Health and Human Services. Report of the Secretary's Task Force Report on Black and Minority Health, vol. I: executive summary. Available from: http:\/\/minorityhealth.hhs.gov\/assets\/pdf\/checked\/1\/ANDERSON.pdf. Accesssed April 24, 2015"},{"key":"10.1016\/j.ajic.2015.08.007_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/lt.23449","article-title":"Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis","volume":"18","author":"Ali","year":"2012","journal-title":"Liver Transpl"},{"issue":"Suppl 3","key":"10.1016\/j.ajic.2015.08.007_bib22","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/677827","article-title":"Racial and ethnic disparities in healthcare-associated infections in the United States, 2009-2011","volume":"35","author":"Bakullari","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.08.007_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhin.2012.11.009","article-title":"Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital","volume":"83","author":"Campbell","year":"2013","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.ajic.2015.08.007_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(14)63762-8","article-title":"Predictors and outcomes of readmission for Clostridium difficile in a national sample of Medicare beneficiaries","volume":"146","author":"Collins","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajic.2015.08.007_bib25","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/ajg.2013.333","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients","volume":"108","author":"Freedberg","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajic.2015.08.007_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu048","article-title":"Determinants of Clostridium difficile infection incidence across diverse United States geographic locations","volume":"1","author":"Lessa","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2015.08.007_bib27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/ajt.12798","article-title":"Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes","volume":"14","author":"Mittal","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajic.2015.08.007_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/663209","article-title":"Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C.\u00a0difficile Burden","volume":"33","author":"Murphy","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.08.007_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/003335491212700107","article-title":"Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008","volume":"127","author":"VerLee","year":"2012","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ajic.2015.08.007_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.08.007_bib31","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2015.08.007_bib32","unstructured":"The White House, Office of Management and Budget. Revisions to the standards for the classification of federal data on race and ethnicity. Available from: https:\/\/www.whitehouse.gov\/omb\/fedreg_1997standards. Accessed May 7, 2015."},{"key":"10.1016\/j.ajic.2015.08.007_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1377\/hlthaff.21.3.91","article-title":"Addressing racial and ethnic barriers to effective health care: the need for better data","volume":"21","author":"Bierman","year":"2002","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ajic.2015.08.007_bib34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1542\/peds.2014-1781","article-title":"Race, otitis media, and antibiotic selection","volume":"134","author":"Fleming-Dutra","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2015.08.007_bib35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/j.gastro.2010.08.023","article-title":"Safety of proton pump inhibitor exposure","volume":"139","author":"Yang","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajic.2015.08.007_bib36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile\u2013associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajic.2015.08.007_bib37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid-suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajic.2015.08.007_bib38","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajic.2015.08.007_bib39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/apt.12425","article-title":"Genetic risk factors for Clostridium difficile infection in ulcerative colitis","volume":"38","author":"Ananthakrishnan","year":"2013","journal-title":"Aliment Pharmacol Ther"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655315008809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655315008809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:44:42Z","timestamp":1759297482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655315008809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0196655315008809"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2015.08.007","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic disparities in health care\u2013associated Clostridium difficile infections in the United States: State of the science","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2015.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}